Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463709 · ClinicalTrials.gov registry record · Phase 1
Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer
A Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01463709: Completed Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01463709 is a Phase 1 study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01463709, a Phase 1 study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Human Basal Cell Carcinomas (BCCs) can be ablated by treating them with nanosecond pulsed electric fields (nsPEF)
Interventions
- DEVICE PulseCure pulse generator and Derm-pulse electrode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01463709
The ClinicalTrials.gov registry entry for NCT01463709 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PulseCure pulse generator and Derm-pulse electrode is the first listed.
NCT01463709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01463709 about?
NCT01463709 is a clinical study titled "Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer". Human Basal Cell Carcinomas (BCCs) can be ablated by treating them with nanosecond pulsed electric fields (nsPEF)
What is the current status of trial NCT01463709?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2011-10. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01463709?
The interventions under investigation include: PulseCure pulse generator and Derm-pulse electrode (DEVICE).
Who is sponsoring clinical trial NCT01463709?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.